Actionable news
0
All posts from Actionable news
Actionable news in CELG: Celgene Corporation,

Celgene Corporation Elects Julia A. Haller, M.D., To Its Board Of Directors

The following excerpt is from the company's SEC filing.

Celgene Corporation (NASDAQ: CELG) today announced the election of Julia A. Haller, M.D., to its Board of Directors. Dr. Haller is Ophthalmologist-in-Chief of the Wills Eye Hospital in Philadelphia, PA where she holds the William Tasman, M.D. Endowed Chair. She serves as Professor and Chair of the Department of Ophthalmology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals, and is Co-Director of the Wills Vision Research Center at Jefferson.

In 1986, Dr. Haller served as the first female Chief Resident at the Wilme r Eye Institute at Johns Hopkins and later joined the Johns Hopkins faculty. She was named the inaugural Katharine Graham Professor of Ophthalmology in 2002, and the inaugural Robert Bond Welch, M.D. Professor of Ophthalmology in 2006. In 2007, Dr. Haller assumed leadership of Wills Eye Hospital.

Dr. Haller, one of the world’s most renowned retina surgeons and clinician-scientists, has received numerous academic and professional honors and awards and has published over 300...


More